Vaccine-preventable severe morbidity and mortality caused by meningococcus and pneumococcus: A population-based study in France
CONCLUSIONS: Mortality and morbidity rates related to vaccine-preventable meningococcal or pneumococcal infection could be reduced by one quarter with better implementation of immunisation programs. Such information could help enhance the perception of vaccine benefits and fight vaccine hesitancy.